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Abstract Objective: In healthy vol-
unteers cerebral blood flow starts to
recover towards baseline within a few
minutes of continued hyperventila-
tion due to normalisation of perivas-
cular pH. We investigated the time-
course of changes in middle cere-
bral artery mean flow velocity (FVm)
and intracranial pressure (ICP) in
head-injured patients during sus-
tained moderate reductions in arte-
rial partial pressure of CO2 (PaCO2).
Design: Observational study.
Patients: Twenty-seven sedated, me-
chanically ventilated patients with se-
vere head injury. Interventions: Mea-
surements were made during and af-
ter routine determination of CO2-re-
activity: an acute 20% increase in
respiratory minute volume was fol-
lowed by a 10-min stabilisation pe-
riod and 50 min of continued mod-
erate hyperventilation at a constant
PaCO2 (>3.5 kPa). Measurements
and results: FVm was monitored with
transcranial Doppler, ICP was moni-
tored with intraparenchymal probes.
During the 50-min period with stable
PaCO2 FVm increased in 36% of
patients. All other patients showed a
decline in FVm over the same time
period. Overall FVm recovery was
0.03€0.14%·min-1. The time-course
of ICP changes was significantly
different from that of FVm, with
ICP reaching its lowest value earlier
than FVm (23€12 vs 37€20 min;
P = 0.001) and returning more
rapidly towards baseline than FVm
(0.23€0.23 vs 0.03€0.14%·min-1;
P< 0.0001). Conclusions: Head-in-
jured patients may adapt differently
to hyperventilation than healthy vol-
unteers. Potentially harmful reduc-
tions in cerebral blood flow may
persist beyond the duration of useful
ICP reduction.
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When healthy volunteers hyperventilate for a prolonged
time-interval their cerebral blood flow (CBF) shows a
relatively rapid adaptation starting almost immediately
after onset of hyperventilation [1, 2], with recovery of
CBF to approximately 90% of baseline values within 4 h
of sustained hypocapnia [3]. This recovery is thought to
be due to the return of cerebral vascular calibre towards
baseline, following the normalisation of intracellular, and
perivascular pH [4].
Hyperventilation has been used for several decades to
reduce intracranial pressure (ICP) in head-injured patients
[5, 6]. However, hyperventilation may have only rela-
tively short-lived effects on ICP, and initial ICP reduc-
tions are often followed by recovery towards baseline,
with restoration of pre-hyperventilation values within
60 min in some patients [7]. It is assumed that the short
duration of the ICP reduction is due to the transient nature
of the underlying vascular changes [8]. However, CBF
responses in head-injured patients may differ from heal-
thy subjects, with no recovery of CBF after 48 h of
continuous hyperventilation in some patients [9].
Most patient studies of CBF adaptation to hyperven-
tilation have focused on intervals of hypocapnia 24 h
[10, 11]. More recently, long-term hyperventilation is less
commonly used, and hypocapnia tends to be used for
short periods to treat critical elevations in ICP [12, 13].
However, there are only sparse data on the short term
responses of cerebral haemodynamics to moderate re-
ductions in arterial partial pressure of CO2 (PaCO2). We
have used transcranial Doppler (TCD) data acquired
during and after routine CO2-reactivity testing to char-
acterise the time-course of CBF changes during the first
60 min after a step decrease in PaCO2. We also tested the
hypothesis that the time-course of changes observed in
ICP is directly related to that seen in FVm. These data
have previously been presented in abstract form [14].
Methods and materials
Data from adult patients (age >16 years) admitted to our
Neurosciences Critical Care Unit (NCCU) with severe or
moderate traumatic brain injury are presented. At the time
of the study all patients had deteriorated to a Glasgow
Coma Score (GCS) 8 and needed continuous ICP
monitoring and mechanical ventilation. As part of the
clinical protocol on the Unit, all patients underwent rou-
tine testing of CO2-reactivity to aid prognostic stratifi-
cation. Data collected from these CO2-reactivity studies
were used for this paper. The collection of these data was
prospectively considered by the multidisciplinary NCCU
Users Group, and it was agreed that because assessment
of CO2-reactivity was part of normal clinical manage-
ment, and since no patient confidentiality issues were
involved, formal informed consent was not required. Ex-
clusion criteria included respiratory failure, a baseline
PaCO2 <4.30 kPa, and failure to obtain satisfactory bi-
lateral TCD signals. All patients were treated according to
a cerebral perfusion pressure (CPP) orientated proto-
col aiming to keep CPP above 70 mmHg, ICP below
25 mmHg, and jugular bulb venous oxygen saturation
(SjO2) above 50% [15]. During the studies all physio-
logical parameters were maintained within the limits
specified in the treatment guidelines of our unit. Outcome
was assessed 6 months after injury using the Glasgow
Outcome Scale (GOS) [16].
Mean arterial blood pressure (MAP) was monitored
via the radial artery (Edwards Lifesciences, Irvine, Ca-
lif., USA). ICP was monitored using an intraparenchy-
mal probe (Codman MicroSensors ICP Transducer,
Codman & Shurtleff, Raynham, Mass., USA). End-tidal
CO2 (ETCO2) was measured using mainstream capno-
graphy (Marquette Solar 8000 M, GE Medical Systems,
UK). Bilateral TCD mean flow velocity (FVm) mea-
surements from the middle cerebral artery (MCA) were
used to assess changes in CBF (Multi Dop X4, DWL
Elektronische Systeme, Sipplingen, Germany). The two
2-MHz probes were held in place with a Lam head rack
[17].
During the study all patients were sedated with pro-
pofol, (2–5 mg·kg-1·h-1) and fentanyl (1–2 mg·kg-1·h-1),
and paralysed (atracurium). Infusion rates of sedative and
vasoactive drugs were not changed and body temperature
was kept constant throughout the study period. After
recording baseline data for 20 min and determination
of baseline PaCO2, the minute volume of the respirator
was increased by 15–20%. If this intervention resulted in
physiological parameters outside treatment guidelines
(PaCO2 <3.5 kPa and/or SJO2 <55%), the protocol was
abandoned. After an initial “stabilisation period” of
10 min the new ETCO2 was maintained for at least
50 min at this level (“stable hyperventilation period”). To
detect a possible protracted equilibration between PaCO2
and ETCO2, PaCO2 was determined at the beginning and
at the end of the stable hyperventilation period. Patients’
whose PaCO2 changed by more than one standard devi-
ation of the total precision of the used blood gas analyser
(AVL Omni, AVL Graz, A-8020 Austria: total precision
of measurements according NCCLS document EP5-T:
SD <0.27 kPa; personal communication, J. Riegebauer,
Roche Diagnostics, Graz, Austria) during the stable hy-
perventilation period were excluded from analysis.
Data were recorded continuously using the analogue
output of the monitors, analogue-digital conversion, and
waveform time integration [18], and stored on a portable
computer for offline analysis. For analysis 1-min mean
values were calculated for all parameters. FVm values
from both hemispheres were averaged. Averaged data of
the 20-min pre-hyperventilation baseline period and the
data from the first minute following the 10-min stabili-
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sation period were used to calculate the relative CO2- and
ICP-reactivity as the percentage change from baseline in
FVm and ICP, respectively, per kPa change in PaCO2.
Despite constant PaCO2 the lowest values of FVm were
rarely reached after exactly 10 min of hyperventilation;
we therefore also calculated the maximal CO2-reactivity,
based on the lowest value for FVm that was reached.
The speed of onset of changes in FVm and ICP were
characterised by the time-constant (t) of the time taken
(tmin) to achieve the lowest values of FVm (FVmmin) and
ICP. Recovery was characterised by the slopes of linear
functions that were fitted to the FVm and ICP data
throughout the stable hyperventilation period (slopetot).
However, using this approach it is possible to miss FVm
recovery occurring relatively late during the stable hy-
perventilation period in patients with a negative slopetot.
Therefore, in these patients we also calculated slopes for
FVm between tmin and the end of the protocol (slopelate),
if at least five data points (i.e., 5 min) were available to fit
the linear regression function. The protocol and analysis
are illustrated in Fig. 1. For comparisons of recovery of
FVm in patients with that of healthy volunteers, previ-
ously published data were used [19]. These data were
acquired using passive hyperventilation.
All data are presented as mean€standard deviation
unless specified otherwise. Data were compared using
paired t-tests with Bonferroni corrections where appro-
priate. For analysis of the interaction between time and
the changes of FVm and ICP in patients and volunteers,
two-way analysis of variance was used. Calculations were
performed using SPSS 11.0 for Windows (SPSS, Chicago,
Ill., USA).
Results
We investigated 30 head-injured patients. In one patient
the study had to be abandoned because SJO2 fell below
55%. Two studies were excluded due to insufficient sta-
bility of PaCO2. Our analysis therefore includes data from
27 patients (four women, 23 men, mean age: 39 years,
range 17–70 years, median GCS at admission: 5.5, range
3–12). Studies were carried out 3.7€2.7 days after injury.
Clinical data and CT findings are summarised in Table 1.
Haemodynamic and PaCO2 data at four time-points dur-
ing the study are presented in Fig. 2. The increase in
minute ventilation reduced PaCO2 from 5.10€0.35 kPa to
4.40€0.34 kPa (0.70€0.27 kPa). CO2-reactivity was
26.5€16.3%·kPa-1. We found no significant correlations
between the day of the study, GCS or GOS and CO2-
reactivity. FVmmin was reached after 37€20 min. The
mean time-constant for onset of FVm reduction due to
hyperventilation was 8.9 min (range 2–48 min). Maximal
CO2-reactivity calculated from FVmmin was significantly
higher than that determined at the beginning of the stable
hyperventilation period (35.4€19.4 vs 26.5€16.3%·kPa-1,
P = 0.001).
FVm recovery
Overall slopetot was 0.03€0.14%·min
-1. A negative
slopetot was observed in 17 (63%) patients, i.e., FVm at
the end of the stable hyperventilation period was lower
than at the beginning of this period. In these 17 pa-
tients we attempted to calculate slopelate. Values ranging
Fig. 1 Schematic illustration of
protocol and analysis. (FVm
MCA mean flow velocity mid-
dle cerebral artery, t time-con-
stant of onset of hyperventila-
tion induced changes, tmin time
interval between start of hyper-
ventilation and lowest observed
value for FVm [FVmmin]).
FVmmin was used to calculate
maximal CO2-reactivity,
whereas “standard” CO2-reac-
tivity was calculated from the
first 1-min mean value of FVm
of the stable hyperventilation
period.
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from –0.05%·min-1 to 0.95%·min-1 (0.18€0.24%·min-1)
were found and seven patients showed evidence of late
recovery (slopelate >0). There were no significant corre-
lations between slopetot or slopelate and the extent of the
change in PaCO2. Raw data of three patients are presented
in Fig. 3. There were no significant correlations between
slopetot and GCS, GOS, or age. Assuming linear recovery,
we estimated the time to complete recovery of FVm in
patients with positive slopetot or slopelate (n = 17). Values
ranged from 81 min to 40 h (mean: 467 min). Using a
general linear model we also addressed the question
whether hemispheric recovery in the presence of a lesion
within the MCA territory on CT is related to FVm re-
covery. However, the presence of a lesion did not sig-
nificantly influence recovery. Comparison with data from
healthy volunteers showed a significantly different time-
course (Fig. 4, two-way ANOVA, significant interaction
(P <0.05) between time and group).
Time-course of ICP changes and comparison with FVm
ICP-reactivity ranged from 2.0%·kPa-1 to 85.7%·kPa-1
(38.8€24.9%·kPa-1). There was a significant correlation
between ICP-reactivity and CO2-reactivity (r
2 = 0.39,
P < 0.001) but no significant correlation between baseline
ICP and ICP-reactivity. The time-constant for onset of the
initial ICP reduction (mean 6 min, range 1–19 min) was
comparable to the one for FVm (P >0.05); however, the
lowest values for ICP were reached significantly earlier
(23€12 min) for ICP than for FVm (P = 0.001). Slopetot
for ICP-recovery was 0.23€0.23%·min-1 (range: -0.07–
0.70%·min-1). In eight patients (30%) ICP had reached or
exceeded baseline ICP by the end of the study. Only five
patients had a negative slopetot for ICP-recovery, but in all
these patients there was evidence of late-onset recovery
with positive values for slopelate. During the stable hy-
perventilation period, ICP changes did not follow those of
FVm. Overall the time-courses of FVm and ICP were
significantly different (significant interaction between
time and ICP and FVm, P< 0.0001, Fig. 5). Looking at
individual patients, of the ten patients with positive slo-
petot three showed recovery of FVm that was faster than
ICP-recovery and in six (including two women) ICP re-
covered faster than FVm. In a single patient FVm and ICP
recovered at approximately equivalent rates. In the 17
patients with negative slopetot one had a similar time-
course for FVm and ICP, in all others (including two
women) ICP recovered more rapidly than FVm. We found
no predictor for the response in FVm and ICP.
Discussion
This study has found a persistent reduction of FVm over
the first hour of moderate hyperventilation in a majority
of patients and a discordance in the time-course of re-
covery of FVm and ICP during sustained moderate hy-
perventilation in head-injured patients.
Crucial to the interpretation of our data is the stability
of PaCO2 during the stable hyperventilation phase. The
precision of blood gas measurements is limited and the
range of PaCO2 values that we accepted as stable is
considerable. In 14 patients we determined PaCO2 at an
additional time-point, and all these values were clearly
within the precision limits specified in the methods sec-
tion (Fig. 2). While smaller PaCO2 variations within the
precision limits would be difficult to quantify but could
affect determination of tmin, they would affect both FVm
and ICP similarly, and would not confound comparisons
between these two variables.
CO2-reactivity in women has been shown to be greater
than in men [20]. To the best of our knowledge there are
no published data concerning gender and adaptation of
CBF to prolonged changes in PaCO2. In our small series
of patients there are only four (premenopausal) women
and our data do not allow us to assess the impact of
gender on the response of CBF to sustained hypocapnia
after head-injury.
Is the decrease in FVm we observed during 1 h of
sustained hyperventilation due to the injury or to
methodological differences between studies in patients
Table 1 Patients: clinical data and CT findings [Day day of study
after injury, GCS Glasgow Coma Score at admission, D I – III
diffuse injury I – III, EML evacuated mass lesion, NEML non-
evacuated mass lesion, GOS Glasgow Outcome Scale (4 patients
lost to follow-up)].
Patient Age Day GCS Marshall score GOS
1 43 8 7 D II
2 18 2 7 D II 4
3 43 4 11 EML 4
4 19 2 3 D I 4
5 49 2 5 D II 1
6 46 2 6 EML 3
7 35 6 3 D II 3
8 53 2 9 D III 3
9 38 4 4 D III
10 26 3 5 EML 4
11 39 2 4 EML 3
12 29 3 4 D II 4
13 47 10 3 D II 3
14 22 3 3 D II 5
15 53 1 6 D I 4
16 55 12 10 EML 5
17 17 5 8 NEML 4
18 22 3 4 D I
19 20 2 8 D II 5
20 65 3 3 D II 1
21 37 2 3 EML 1
22 25 2 8 D I 5
23 23 4 8 EML 3
24 70 1 12 NEML 4
25 64 2 8 EML 3
26 47 4 3 D II 1
27 50 6 6 EML
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and volunteers? Volunteer studies have mostly been per-
formed using active hyperventilation. It could be argued
that hyperventilation leads to cerebral activation that is at
least partly responsible for the observed recovery of CBF.
However, we used passive hyperventilation in our vol-
unteers [19] and the rate of recovery that we saw using
this method is comparable to earlier studies using active
hyperventilation [1, 2]. This makes it unlikely that the
observed difference is due to this methodological aspect.
Another aspect that makes comparisons between volun-
teer and patient studies difficult is the effect of treatment.
Our patients were sedated with propofol and were com-
monly receiving vasoactive drugs such as dopamine and
noradrenaline. These factors could theoretically interfere
with CBF recovery. Whilst in the presence of propofol
CO2-reactivity is preserved, albeit somewhat reduced [21,
22], the effects of propofol, noradrenaline, and dopamine
on CBF adaptation to sustained hypocapnia have not been
investigated. A further concern is the influence of arterial
partial pressure of O2 (PaO2) on recovery of FVm. It has
recently been shown that hyperoxia when compared to
normoxia reduces FVm recovery in healthy volunteers
[19]. However, we found no correlation between PaO2
and slopetot in our patients. Our data do not allow us to
draw conclusions as to whether the observed pattern is
due to therapy or to the injury per se. But the fact that
there was no relation between the time-course of adap-
tation and admission GCS, presence of a lesion within the
Fig. 2 Haemodynamic data at
four time-points during the
protocol. Data are shown as
mean€SD. Dashed lines re-
present€1 SD of precision of
blood gas measurements.
[PaCO2 arterial partial pressure
of CO2, FVm mean flow ve-
locity in the middle cerebral
artery (mean of both hemi-
spheres), MAP mean arterial
blood pressure, ICP intracranial
pressure, CPP cerebral perfu-
sion pressure,† ICP increased
significantly (P <0.01) between
start and end of the stable hy-
perventilation period (paired t-
tests with Bonferroni correc-
tion)]. *P< 0.01 between base-
line and start stable hyperven-
tilation.
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Fig. 3 Examples of time-course
of flow velocity in three pa-
tients. (FVm mean flow veloci-
ty, ICP intracranial pressure,
MCA middle cerebral artery,
PaCO2 arterial partial pressure
of CO2).
Fig. 4 Comparison of recovery
of FVm in head-injured patients
and healthy volunteers. Pooled
data from 27 patients and nine
healthy volunteers (mean€-
SEM), showing more rapid re-
covery of middle cerebral artery
mean flow velocity (average
value of both hemispheres) in
volunteers. Two-way ANOVA,
significant interaction (P <0.05)
between time and group.
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MCA territory on CT, or outcome suggests that our ob-
servations are not only related to the injury per se. Further
studies are needed to address this question.
ICP reductions with hyperventilation are generally
attributed to changes in cerebral blood volume (CBV),
and the concordant reductions in FVm and ICP with the
induction of hyperventilation suggests that an alteration
in cerebral vascular calibre was responsible for both
changes. However, the clear discordance in the recovery
patterns of these two parameters with continued hyper-
ventilation suggests that different mechanisms were op-
erating for CBF and CBV recovery during this period.
The discordance in CBF and ICP recovery patterns may
be due to effects in separate microvascular compartments;
however, our data do not allow us to test this hypothesis.
ICP recovery may be caused by the transient effects of
hypocapnia in a segment of the vascular tree that is not
investigated by TCD, e.g., the venous compartment, while
the effect of hypocapnia on arterial resistance vessels and
hence CBF may be more persistent. However, changes in
one or more of the other intracranial compartments, ce-
rebrospinal fluid (CSF), and brain volume, also need to be
considered. Data are available on changes in CSF volume
with hyperventilation in the setting of intracranial hy-
pertension. Artru [23] studied the effects of hypocapnia in
dogs with a simulated intracranial mass, and found a re-
duction in ICP for the complete duration of a 4-h study,
despite CBV re-expansion to baseline values during the
studies. The mechanism responsible was a concomitant
reduction in CSF volume, probably due to a hypocapnia-
induced improvement in the access of intracranial CSF to
spinal sites of CSF absorption. Production of CSF did not
change during the study. While the literature provides no
information regarding compartmental changes in brain
tissue volume with hyperventilation, Artru’s study did not
find an increase in total brain tissue water. By avoiding
low SJO2 we attempted to avoid hyperventilation-induced
ischaemia. However, we cannot exclude that the ICP in-
creases may have been at least partly induced by devel-
oping cytotoxic oedema. While further studies are needed,
we believe that the present data support the inference that
the discordant changes in CBF and ICP recovery patterns
are due to changes in CBV in a vascular compartment not
accessible to investigation with TCD, possibly the venous
circulation. However, the studies by Artru [23] were
conducted in animals without head trauma, and we cannot
exclude the possibility that CSF-related mechanisms may
contribute to this process.
Since these data were acquired as a part of routine
CO2-reactivity testing, we were constrained by the pro-
tocol used in our unit for this purpose. Consequently, we
acquired data for a maximum of 60 min of hyperventi-
lation, and discontinued hyperventilation if there was any
evidence of jugular venous desaturation. This limits the
applicability of our results to understanding the physio-
logical effects of sustained hyperventilation beyond this
time frame, as might be employed in some patients with
intracranial hypertension.
Our data raise the question which is the best time-point
for determination of CO2-reactivity after a change in
PaCO2? Generally, for determination of CO2-reactivity
methods similar to ours are used [24, 25, 26], and reac-
tivities are calculated 10 min or 15 min after changing the
ventilator settings. Such a time-point may not represent
the maximal response in many patients, but rather an ar-
bitrary value that may depend on the rate and extent
Fig. 5 Time-course of changes
in mean flow velocity, intra-
cranial pressure and cerebral
perfusion pressure in patients.
Pooled data from all patients
(mean€SEM), showing more
rapid recovery of intracranial
pressure than middle cerebral
artery mean flow velocity (av-
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of induction of hypocapnia. Techniques that depend on
steady-state intracranial haemodynamics with data col-
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tomography, need to be interpreted in the light of the
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trapolated beyond the time frame of the study.
In summary, our results show that the adaptation to
sustained reductions in PaCO2 in patients may be differ-
ent from that observed in healthy volunteers. It is unclear
whether this difference is due to treatment or the injury
per se. During sustained hyperventilation in head-injured
patients, adaptation of CBF has a different temporal
profile than the changes in ICP and the beneficial effect of
hypocapnia on ICP may be outlived by potentially
harmful decreases in CBF.
Acknowledgements We thank Hugh Richards (Academic Neuro-
surgery, University of Cambridge, UK) and Raymond Salvador
(Wolfson Brain Imaging Centre, University of Cambridge) for
statistical advice. M. Czosnyka is on unpaid leave from the Warsaw
University of Technology, Poland
